The activation of the human epidermal growth factor receptor-2 (HER2) gene, whose downstream signal transduction pathways include MAPK and PI3K/AKT/mTOR, leads to cell proliferation and differentiation, thus inhibiting apoptosis and tumor progression (Guarini et al., 2021). This evidence concerns the gene ERBB2 and neoplasm.